Details of Bacterial Vaccine
This bacterial vaccine card gives comprehensive information about each vaccine.
| Detailed Information | |
|---|---|
| ID | 1333 |
| Name of the vaccine | CVD 909 |
| Microbe | Bacteria |
| Disease name | Typhoid |
| Name of bacteria | Salmonella typhi |
| Type of vaccine | Live attenuated |
| Nucleic acid content | DNA |
| Age | 18 to 40 years |
| Description of the vaccine | Vi Polysaccharide typhoid vaccine after priming by live attenuated oral Vi+ Salmonella Typhi strain CVD 909. |
| Name of the manufacturer | National Institute of Allergy and Infectious Diseases (NIAID) |
| Name of the manufacturing country | United States |
| Year of manufacture | 2008 |
| Clinical Phase status | Clinical - Phase 1 |
| Bacterial strain | Gram negative bacteria |
| Efficacy | NA |
| Vaccine formulation | Oral dose |
| Dosage | Single dose given with buffer. |
| Mechanism of action | Serum IgG anti-Vi antibodies inducing both Th1/Th2-type immunity. |
| Route of administration | Oral |
| Indications | NA |
| Export | NA |
| Approval | NA |
| Adjuvant | NA |
| Repurposing | NA |
| Side effects of vaccine | NA |
| Post vaccination | NA |
| Dose type | Single dose |
| Interspecies transfer | NA |
| PubMed identifier | NA |
| Clinical trial number | NCT00326443 |
| Reference | NA |
| Other name | NA |
| Additional Links | NA |